A collaborative investigation by researchers at Brigham and Women's Hospital and Johns Hopkins University created a cancer treatment that utilizes mesenchymal stem cells and microparticles. Both components of the treatment are engineered to specifically target and kill cancer cells.
Chemotherapeutic agents are highly effective at killing cellular components--both cancerous and benign. A major challenge in cancer treatment is finding the balance in this tradeoff. The most effective chemotherapy isolates cancerous cells while avoiding systemic cellular havoc. For the study, mesenchymal stem cells loaded with microparticles containing chemotherapeutic drugs were designed to seek out tumors.. The researchers hope their novel approach in drug delivery can be applied to different drugs, targeting an array of diseases.
The Brigham Women’s Hospital’s innovative research demonstrates the integral role stem cell therapies will soon play in cutting edge medical care options. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.